Clinical Trial Update: Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia [Phase 3]

View source ↗

Summary

Takeda-sponsored Phase 3 trial evaluating lapaquistat acetate for hypercholesterolemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED